These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 39163678)

  • 1. The emerging role of the gut microbiota and its application in inflammatory bowel disease.
    Wang X; Peng J; Cai P; Xia Y; Yi C; Shang A; Akanyibah FA; Mao F
    Biomed Pharmacother; 2024 Oct; 179():117302. PubMed ID: 39163678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Lee M; Chang EB
    Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation.
    Wu R; Xiong R; Li Y; Chen J; Yan R
    J Autoimmun; 2023 Dec; 141():103062. PubMed ID: 37246133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
    Oka A; Sartor RB
    Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
    Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
    World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
    Eindor-Abarbanel A; Healey GR; Jacobson K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the fecal microbiota in inflammatory bowel disease.
    Khalaf R; Sciberras M; Ellul P
    Eur J Gastroenterol Hepatol; 2024 Nov; 36(11):1249-1258. PubMed ID: 38973540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
    Tie Y; Huang Y; Chen R; Li L; Chen M; Zhang S
    Gut Microbes; 2023 Dec; 15(2):2265028. PubMed ID: 37822139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future microbiome-based therapies in inflammatory bowel disease.
    Montrose JA; Kurada S; Fischer M
    Curr Opin Gastroenterol; 2024 Jul; 40(4):258-267. PubMed ID: 38841848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional Support and Probiotics as a Potential Treatment of IBD.
    Tarasiuk A; Eibl G
    Curr Drug Targets; 2020; 21(14):1417-1427. PubMed ID: 32364071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
    Weingarden AR; Vaughn BP
    Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healing from Within: How Gut Microbiota Predicts IBD Treatment Success-A Systematic Review.
    Alexandrescu L; Nicoara AD; Tofolean DE; Herlo A; Nelson Twakor A; Tocia C; Trandafir A; Dumitru A; Dumitru E; Aftenie CF; Preotesoiu I; Dina E; Tofolean IT
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.